Evidence map›Paper›PMID 31744174›Full record

ArticleCancers2019

Complex Formation with Monomeric α-Tubulin and Importin 13 Fosters c-Jun Protein Stability and Is Required for c-Jun's Nuclear Translocation and Activity.

Melanie Kappelmann-Fenzl, Silke Kuphal, Rosemarie Krupar, Dirk Schadendorf, Viktor Umansky, Lily Vardimon, Claus Hellerbrand, Anja-Katrin Bosserhoff

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Melanie Kappelmann-FenzlInstitute of Biochemistry (Emil-Fischer Center), Friedrich-Alexander University, Erlangen-Nürnberg, 91054 Erlangen, Germany.
Silke KuphalInstitute of Biochemistry (Emil-Fischer Center), Friedrich-Alexander University, Erlangen-Nürnberg, 91054 Erlangen, Germany.
Rosemarie KruparPathology of the University Medical Center Schleswig-Holstein, Campus Lübeck and Research Center Borstel, Leibniz Center for Medicine and Biosciences, 23566 Lübeck, Germany.
Dirk SchadendorfDepartment of Dermatology, University Duisburg-Essen, 45355 Essen, Germany.
Viktor UmanskyDepartment of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, 69117 Heidelberg, Germany.
Lily VardimonDepartment of Biochemistry and Molecular Biology, Tel Aviv University, 69978 Tel Aviv, Israel.
Claus HellerbrandInstitute of Biochemistry (Emil-Fischer Center), Friedrich-Alexander University, Erlangen-Nürnberg, 91054 Erlangen, Germany.
Anja-Katrin BosserhoffInstitute of Biochemistry (Emil-Fischer Center), Friedrich-Alexander University, Erlangen-Nürnberg, 91054 Erlangen, Germany.ORCID 0000-0001-8147-394X
Friedrich-Alexander-Universität Erlangen-Nürnberg · DEHeidelberg University · DETel Aviv University · ILUniversity of Duisburg-Essen · DE

Funding

Deutsche Forschungsgemeinschaft FOR2127Deutsche Krebshilfe AB
6 · The paper itself

Abstract

Microtubules are highly dynamic structures, which consist of α- and β-tubulin heterodimers. They are essential for a number of cellular processes, including intracellular trafficking and mitosis. Tubulin-binding chemotherapeutics are used to treat different types of tumors, including malignant melanoma. The transcription factor c-Jun is a central driver of melanoma development and progression. Here, we identify the microtubule network as a main regulator of c-Jun activity. Monomeric α-tubulin fosters c-Jun protein stability by protein-protein interaction. In addition, this complex formation is necessary for c-Jun's nuclear localization sequence binding to importin 13, and consequent nuclear import and activity of c-Jun. A reduction in monomeric α-tubulin levels by treatment with the chemotherapeutic paclitaxel resulted in a decline in the nuclear accumulation of c-Jun in melanoma cells in an experimental murine model and in patients' tissues. These findings add important knowledge to the mechanism of the action of microtubule-targeting drugs and indicate the newly discovered regulation of c-Jun by the microtubule cytoskeleton as a novel therapeutic target for melanoma and potentially also other types of cancer.

Indexed as

AP1c-Junimportintranscription factortubulin

Identifiers

PMID31744174
PMCPMC6895814
OpenAlexW2984274687

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.